Status:
UNKNOWN
Evaluation of Hearing Aids Rehabilitation Within Age-related Hearing Loss Population.
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hearing aids restore efficiently some auditory functions in age-related hearing loss (ARHL or presbycusis) providing to the elderly an access to oral communication and a return to social life. However...
Detailed Description
The main objective is to evaluate the hearing aids benefits for spatial hearing with a multidisciplinary approach combing psychophysics, and Positron Emission Tomography (PET) brain imaging in a befor...
Eligibility Criteria
Inclusion
- For presbyacusics subjects:
- Subjects aged over 50 with a difference in symmetrical audiometric thresholds (\< 15 dB) between the two ears and requiring hearing aids
- Affiliation to a social security scheme or equivalent
- Acceptance of the protocol and signature of the consent form
- For older people with normal hearing:
- Subjects matched in age (+/- 2 years) and gender with the presbycusis group
- Affiliation to a social security scheme or equivalent
- Acceptance of the protocol and signature of the consent form
- Subjects with normal hearing, with hearing thresholds of 20 dB \< 2kHz and 40 dB \< 4kHz
- For young people with normal hearing:
- Subjects aged between 18 and 40 years old,
- Symmetric normal hearing
- Affiliation to a social security scheme or equivalent
- Normally hearing subjects with audiometric thresholds \< 20 dB
- Acceptance of the protocol and signature of the consent form
Exclusion
- Persons under a legal protection regime for adults (safeguard of justice, guardianship, curator ship, institutionalized, or under mandate for future protection)
- History of associated neurological pathology
- Contraindications to PET
- Cognitive impairment confirmed by the Montreal Cognitive Assessment (MOCA) test (for presbyacusic subjects and normal-hearing elderly subjects)
- Taking psychotropic drugs
- History of epilepsy
- Pregnant or breastfeeding woman
- Participation in another intervention protocol
Key Trial Info
Start Date :
June 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05331404
Start Date
June 2 2022
End Date
April 1 2024
Last Update
July 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Toulouse
Toulouse, France, 31059